Going on a NAV basis, I'd say it's around 50% undervalued.Looking at the quarterly $2.7mill was in one off costs. If they don't have any capital costs this quarter......
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025